NeuroSense Therapeutics Ltd. (NRSN) stock
NRSNNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NRSNW
$1.37−0.14 (-9.27%)
Close on Nov 18, 2026Market cap $2.52MP/E –Yield –
NeuroSense Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
NeuroSense Therapeutics's market cap was $3.27M on Nov 11, 2026, against $29.28M a year earlier. Over the last 5 years it ranged from $58.04K to $43.90M, with a median of $17.70M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.27M | -82.7% |
| 2025 | Dec 31, 2025 | $18.92M | -12.7% |
| 2024 | Dec 31, 2024 | $21.67M | +21804.8% |
| 2023 | Dec 29, 2023 | $98.91K | -98.7% |
| 2022 | Dec 30, 2022 | $7.62M | – |
See a number that looks wrong?